Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Revenue (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed Revenue for 2 consecutive years, with $251000.0 as the latest value for Q1 2024.

  • Quarterly Revenue changed N/A to $251000.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $251000.0 through Dec 2024, changed N/A year-over-year, with the annual reading at $251000.0 for FY2024, 99.25% down from the prior year.
  • Revenue for Q1 2024 was $251000.0 at Artiva Biotherapeutics, down from $2.4 million in the prior quarter.
  • The five-year high for Revenue was $26.7 million in Q3 2023, with the low at $251000.0 in Q1 2024.